Biotechnology company and drug delivery platform innovator
Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) technology is patent protected
for cannabidiol and all other nonpsychoactive cannabinoids. The company also
currently has patents pending for THC, nonsteroidal anti-inflammatory drugs
(NSAIDs), nicotine, other psychoactive cannabinoids and other molecules. An
article discussing the company reads, “Lexaria Bioscience has 10 patents granted
with over 50 patents pending. Four of the granted patents focus on the delivery
of nicotine. The company is not partnering with the tobacco industry. However,
Bunka informed that Lexaria is exploring the potential use of its DehydraTECH
technology to help people stop smoking. . . . The company’s technology has been
shown to deliver nicotine to the brain quicker than traditional delivery
systems. The goal for Lexaria is to put nicotine into some type of oral form to
eliminate the need for inhalation and help people curb their smoking habits.
DehydraTECH studies in 2018 included two animal studies that delivered
pioneering results highlighting the improvements of nicotine delivery to blood
plasma and across the blood-brain barrier (http://ibn.fm/QOjnR).”
To view the full article, visit http://ibn.fm/nm4RB
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and quicker onset of lipophilic active molecules. Lexaria has
ten patents granted in the United States and Australia, and has filed over 50
patent applications worldwide across 10 patent families. Lexaria’s technology
provides more rapid delivery to the bloodstream, as well as important
taste-masking benefits for orally administered bioactive molecules including
cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine
and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment